On April 25, 2024, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed Steven H. Stein, M.D. to serve as a Class II director of the Company, effective as of the Annual Meeting Date.
Departed
Todd Foley
Class I Director
Repare Therapeutics Inc.
Effective
2024-06-17
Filed
April 26, 2024, 7:59 PM ET
On April 24, 2024, Todd Foley notified the board of directors (the “ Board ”) of Repare Therapeutics, Inc. (the “ Company ”) of his decision not to stand for re-election as a Class I director following the end of his current term on June 17, 2024
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Steven H. Stein was appointed as Class II Director at Repare Therapeutics Inc..
Action
appointed
Role
Class II Director
Exact text from the filing
On April 25, 2024, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed Steven H. Stein, M.D. to serve as a Class II director of the Company, effective as of the Annual Meeting Date.
Todd Foley departed as Class I Director at Repare Therapeutics Inc..
Action
not stand for re-election
Role
Class I Director
Exact text from the filing
On April 24, 2024, Todd Foley notified the board of directors (the “ Board ”) of Repare Therapeutics, Inc. (the “ Company ”) of his decision not to stand for re-election as a Class I director following the end of his current term on June 17, 2024
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.